Paul Nouri
View Paul Nouri's Articles BY TICKER:
-
The Fed Controls Interest Rates... For Now
on Wed, Mar 27 • 11 Comments
-
The False Link Between Higher Stocks And A Stronger Economy
-
If Quest Returns To Its Core Strengths, It Can Deliver Big Returns For Shareholders
-
Enzo Investors Have To Be In It For The Long Haul
- After Nearly Doubling In 2 Months, Shares Of Best Buy Appear To Trade At Fair Value
- Risk/Reward For Shares Of Albany Molecular Are Balanced After A 300% Run Up In Shares
- Cynosure's Purchase Of Palomar Is A Natural Step In The Evolution Of The Aesthetic Laser Light Industry
- Digirad Is A Compelling Investment Opportunity With Little Downside Risk
- Best Buy Is Down, But Not Out
- Profiting From The Trend Towards Point Of Care Diagnostics
- CardioNet Reinventing Itself By Consolidating The Monitoring Space
- Time To Start Taking Profits On Gentiva
- Don't Buy The Supervalu Dip
- As China Medical Approaches $10, Investors Should Begin Taking Profits
- Investors Should Be More Focused On Data, Less Focused On Rumors Of Monetary Stimulus
- Investors Short Shares Of China Medical Continue Taking Significant Risk
- Volatility In Home Health Sector Creates Opportunity
- Labcorp's Acquisition Of Medtox Leaves Enzo As An Attractive Investment Opportunity
- Albany Molecular Turnaround Provides Investment Opportunity
- Anderson Family Offer To Acquire Books-A-Million Likely UnderValues Company
- The Healthcare System Is Not Perfect, But Free Market Solutions Exist
- Analysts And Investors Are Too Excited About The SXC Health Solutions Deal
- Approved Express Scripts Merger Paves Way For Distributors
- China Medical Is A Mystery That Most Investors Can't Explain
- The Market Is Getting Ahead Of Itself On The Promise Of More Quantitative Easing
- Investors Should Wait Out Quest And LabCorp
- AngioDynamics' Shareholders Should Be Rewarded With Recent Acquisition, But Patience Is Required
- NeuroMetrix Is Better Positioned After Share Raise
- Corning Can Leverage Itself Into A Modern Industrial Growth Story
- Hill-Rom Looks Like An Attractive Stock For Value Investors
- Shares Of Weight Watchers Look Heavy At $70
- Investors Should Stay On Sidelines Despite 28% Drop In WebMD Shares